Clinical Trials List
2021-12-27 - 2024-07-10
Phase III
Terminated5
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 蔡尚峰 Division of General Internal Medicine
- TUNG-MIN YU Division of General Internal Medicine
- 吳軍毅 Division of General Internal Medicine
- CHENG-HSU CHEN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- I-jen Chiu Division of General Internal Medicine
- Chia-Te Liao Division of General Internal Medicine
- 林冠宏 Division of General Internal Medicine
- Yu-Wei Chen Division of General Internal Medicine
- Mei-Yi Wu Division of General Internal Medicine
- Li-Yee Hong Division of General Internal Medicine
- Cai-Mei Zheng Division of General Internal Medicine
- YUNG-HO HSU Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊紹佑 Division of General Internal Medicine
- Yung-Ming Chen Division of General Internal Medicine
- - - Division of General Internal Medicine
- CHUN-FU LAI Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Cheng-Chia Lee Division of General Internal Medicine
- Guan-Hsing Chen Division of General Internal Medicine
- Chih-Shiang Chang Division of General Internal Medicine
- HSIANG-HAO HSU Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王怡寬 Division of General Internal Medicine
- 周哲毅 Division of General Internal Medicine
- 張耘綸 Division of General Internal Medicine
- 江長城 Division of General Internal Medicine
- 張育瑞 Division of General Internal Medicine
- 王捷賢 Division of General Internal Medicine
- 林詩怡 Division of General Internal Medicine
- 郭慧亮 Division of General Internal Medicine
- 朱書緯 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
666 participants
